Novo Holdings A/S - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,510,490
+12.2%
1,001,000
+8.8%
1.52%
+7.3%
Q2 2023$18,280,400
+16.0%
920,0000.0%1.41%
+35.9%
Q1 2023$15,759,600
-5.3%
920,000
+8.2%
1.04%
+0.1%
Q4 2022$16,634,500
+64.7%
850,000
+34.3%
1.04%
+115.6%
Q3 2022$10,100,000
+16.0%
632,8220.0%0.48%
+12.4%
Q2 2022$8,708,000
-10.4%
632,822
+3.3%
0.43%
-16.4%
Q1 2022$9,719,000
-27.4%
612,8220.0%0.51%
-19.0%
Q4 2021$13,378,000
-16.2%
612,822
+14.7%
0.63%
-23.4%
Q3 2021$15,964,000534,0850.83%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders